vivo pharmacological studies AFT25-DC-004828
Past New Requirement Updated
- Agency
-
Drug Enforcement Administration
Department of Justice
- Solicitation expected
- Estimated value
- $700,001 to $750,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Forecast number
- FY25-DEA-1524-84-12
- Points of contact
-
- DEA Small Business Program deasmallbusinessprogram@dea.gov
Forecast details come from the Justice Department's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Drug Enforcement Administration seeks qualified contractors to conduct in vivo pharmacological studies focused on the valuation of abuse potential of synthetic opioids. This scientific research effort requires specialized expertise in pharmacological assessment methodologies and the evaluation of controlled substance characteristics. The solicitation is expected to be released on January 1, 2026, with an estimated award date of April 1, 2026.
The forecasted contract award value ranges from $700,001 to $750,000, with performance to be conducted at 2560 King Arthur Boulevard, Suite 102, Lewisville, Texas 75056. This procurement falls under the Other Scientific and Technical Consulting Services category (NAICS 541690) and is classified as a special studies/analysis contract related to medical and health matters. Interested contractors should contact the DEA Small Business Program at deasmallbusinessprogram@dea.gov for additional information and to express capability.
Forecast text
valuation of abuse potential of synthetic opioids using in vivo pharmacological studies
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast